West Virginia 2025 Regular Session

West Virginia House Bill HB2403

Introduced
2/17/25  

Caption

Remove hormone blockers from transgender code

Impact

If enacted, the bill would significantly alter the landscape of medical practices concerning the treatment of transgender minors in West Virginia. It would effectively ban the use of hormone blockers and other gender-related medical interventions for individuals under 18, except in defined circumstances, such as those born with medically verifiable disorders of sex development. Critics of the bill express concerns about the potential for increased mental health issues among transgender youth, claiming that access to appropriate medical care is critical for mitigating risks of depression and anxiety related to gender dysphoria.

Summary

House Bill 2403 proposes to amend the West Virginia Medical Practice Act by prohibiting the administration of hormone therapy, specifically gender-altering medications, to individuals under the age of 18. The bill categorizes hormone therapy as a medical treatment targeted at minors, which has spurred extensive debate regarding the rights of minors to access gender-affirming care. Advocates for the bill argue it serves as a necessary protection for children, asserting that minors may not possess the maturity to make irreversible decisions about their medical treatment related to gender identity.

Sentiment

The sentiment surrounding HB2403 is deeply divided. Proponents maintain that the bill is a precautionary measure meant to protect children from making permanent decisions that they may regret in the future. On the other hand, opponents argue that the bill undermines the rights of minors to receive needed medical care and disregards established medical practices that support the mental health and well-being of transgender youth. The debate is reflective of broader national conversations about gender identity and the rights of LGBTQ+ individuals.

Contention

Key points of contention in the discussions surrounding HB2403 include the definitions of biological sex and gender, as provided within the text of the bill. There are arguments about the implications this bill may have on healthcare providers and the rights of families to make medical decisions for their children. Many medical professionals and advocates for transgender rights criticize the bill as an infringement on medical autonomy and argue that it may negatively affect the health outcomes and quality of life for transgender minors seeking constructive support and treatment.

Companion Bills

WV HB2466

Similar To To eliminate the use of puberty blockers for any minor under the age of 18

Previously Filed As

WV SB1011

Expiring funds from Department of Revenue, PEIA Rainy Day Fund

WV SB1012

Expiring funds to Department of Arts, Culture, and History from Lottery Education Fund

WV HB116

Relating to authorizing the Public Employee Insurance Agency to provide insurance coverage for certain prescribed weight loss medications

WV HB111

Expiring funds to the unappropriated surplus balance in the State Fund, General Revenue, from the Department Revenue, State Budget Office, PEIA Rainy Day Fund

WV SB1015

Amending amount of surplus deposited into Revenue Shortfall Reserve Fund

WV HB115

Relating to the amount of surplus deposited into the Revenue Shortfall Reserve Fund and providing for an effective date

WV SB1013

Prohibiting payment to residential substance use disorder treatment facilities in certain circumstances

WV HB113

Prohibiting payment to residential substance use disorder treatment facilities that do not meet certain requirements

WV SB1006

Making supplementary appropriation to Bureau for Medical Services, Policy and Programming, and to BOE

WV HB106

Making a supplementary appropriation to the Department of Human Services, Bureau for Medical Services – Policy and Programming and State Board of Education – State Department of Education

Similar Bills

No similar bills found.